<DOC>
	<DOCNO>NCT02142309</DOCNO>
	<brief_summary>Type 2 diabetes epidemic treatment become difficult . Consensus algorithm develop help clinician select among numerous medication combination achieve maintain target glycated hemoglobin A1c ( HbA1c ) &lt; 7 % . AMAZING , pragmatic clinical trial , aim compare commonly use oral diabetes medication , combine metformin , glycemia-lowering effectiveness .</brief_summary>
	<brief_title>Glycemic Durability After Metformin Failure</brief_title>
	<detailed_description>- Source data verification : paper electronic medical record . - Statistical analysis : All analysis compare randomly assign treatment group intention- to-treat principle</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vildagliptin</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Canagliflozin</mesh_term>
	<criteria>Newlydiagnosed , type 2 diabetic patient , fail diet Suspected type 1 diabetes secondary diabetes result specific cause Current previous ( within past 3 month ) treatment investigational drug Any major cardiovascular event previous year Plans pregnancy course study woman childbearing potential Serum creatinine level &gt; 1.3 mg/dL woman &gt; 1.4 mg/dL men History cancer , nonmelanoma skin cancer , require therapy 5 year randomization Treatment oral , loal , systemic glucocorticoid 14 . Treatment atypical antipsychotic</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>